GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sichuan Biokin Pharmaceutical Co Ltd (SHSE:688506) » Definitions » Additional Paid-In Capital

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Additional Paid-In Capital : ¥0 Mil(As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Sichuan Biokin Pharmaceutical Co Additional Paid-In Capital?


Sichuan Biokin Pharmaceutical Co's quarterly additional paid-in capital increased from Sep. 2023 (¥0 Mil) to Dec. 2023 (¥858 Mil) but then stayed the same from Dec. 2023 (¥858 Mil) to Mar. 2024 (¥0 Mil).

Sichuan Biokin Pharmaceutical Co's annual additional paid-in capital increased from Dec. 2021 (¥14 Mil) to Dec. 2022 (¥858 Mil) but then stayed the same from Dec. 2022 (¥858 Mil) to Dec. 2023 (¥858 Mil).


Sichuan Biokin Pharmaceutical Co Additional Paid-In Capital Historical Data

The historical data trend for Sichuan Biokin Pharmaceutical Co's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sichuan Biokin Pharmaceutical Co Additional Paid-In Capital Chart

Sichuan Biokin Pharmaceutical Co Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 252.83 13.77 13.77 858.07 858.07

Sichuan Biokin Pharmaceutical Co Quarterly Data
Dec11 Dec12 Dec13 Dec14 Jun15 Dec18 Dec19 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 858.07 - 858.07 -

Sichuan Biokin Pharmaceutical Co Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sichuan Biokin Pharmaceutical Co Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sichuan Biokin Pharmaceutical Co's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sichuan Biokin Pharmaceutical Co (SHSE:688506) Business Description

Traded in Other Exchanges
N/A
Address
No. 161, Baili Road, No. 1, Building 1, Cross-strait Science and Technology Industrial Park, Wenjiang District, Sichuan Province, Chengdu, CHN, 611130
Sichuan Biokin Pharmaceutical Co Ltd is a chemical drug and biological drug-based company that integrates drug research and development, production and marketing.

Sichuan Biokin Pharmaceutical Co (SHSE:688506) Headlines

No Headlines